Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:20 PM
Ignite Modification Date:
2025-12-26 @ 10:20 PM
NCT ID:
NCT03134612
Eligibility Criteria:
Inclusion Criteria:
* Subjects aged 18-65 years old
* Subjects were planned to undergo general anesthesia with propofol
* Subjects with Body Mass Index (BMI) 18-35 kg/m2
* Subjects with American Society of Anesthesiologists (ASA) physical status of I-II
* Subjects with signed informed consent.
Exclusion Criteria:
* Subjects with allergies to propofol, lidocain, ondansetron
* Subjects with massive cardiac disorder
* Subjects with cardiac rhythm disorder with or without treatment
* Subjects with unstable hemodynamic
* Subjects with contraindication to propofol, lidocain, ondansetron
* Subjects with intubation and ventilation difficulty
* Subjects with decreased consciousness, seizure history or head injury
* Subjects with analgesic treatment history
* Subjects with pregnancy.
Drop out criteria:
* Subjects with allergic reactions induced by propofol, lidocain, ondansetron
* Uncooperative subjects
* Subjects in emergency
* Subjects with difficult vein access in the dorsum manus
* Subjects with infection and/or inflammation in the planned intravenous cannulation location.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT03134612
Study Brief:
Protocol Section:
NCT03134612